Direxion Daily S&P Biotech Bull 3X ETF
LABU
LABU
39 hedge funds and large institutions have $56.9M invested in Direxion Daily S&P Biotech Bull 3X ETF in 2025 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 10 increasing their positions, 10 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
0.9% more ownership
Funds ownership: 6.4% → 7.3% (+0.9%)
0% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 10
Holders
39
Holding in Top 10
1
Calls
$109M
Puts
$74.3M
Top Buyers
| 1 | +$6.49M | |
| 2 | +$3.57M | |
| 3 | +$2.87M | |
| 4 |
Morgan Stanley
New York
|
+$2.55M |
| 5 |
Goldman Sachs
New York
|
+$2.49M |
Top Sellers
| 1 | -$15.6M | |
| 2 | -$6.2M | |
| 3 | -$2.21M | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$444K |
| 5 |
RC
RBF Capital
San Francisco,
California
|
-$378K |
